NewLimit Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
13:00
Nov 06
Nov 06
ILTB Podcast
AI-native biotech could produce trillion-dollar outcomes.
Leaving out the near-term IPO candidates, he names NewLimit, Chai Discovery and Isomorphic Labs among the next-generation companies investors will definitely have wanted exposure to in this vintage. They are AI-native next-generation biotech with possible $500B to $1T+ outcomes if they execute, and they have the best teams, the best investors and the capital they need. He discloses no position.
NewLimit
NewLimit
Long
—
—
About NewLimit Investor Commentary
Across the available history and selected sources, Buzzberg tracks NewLimit across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: Ramtin Naimi.